MedPath

Effect of Vasa Avaleha and its granules on Tamaka Shwasa (Bronchial Asthma)

Phase 1
Conditions
Health Condition 1: null- Patients suffering from Asthma
Registration Number
CTRI/2012/12/003184
Lead Sponsor
Institute for post gradute teaching and research in ayurved
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

1.Both the sexes having age between 12 years to 70 years

2.Mild persistent cases of Asthma (as per WHO GINA Guideline) of duration more than 6 months.

3.Symptoms/exacerbation (Wheeze, cough and breathlessness) greater than weekly and less than daily in frequency.

4.Night symptoms twice per month but less than once a week.

Exclusion Criteria

1.Age more than 70 years and below 12 years.

2.Mild intermittent, Moderated persistent, severe persistent to severe Asthma.

3.Dyspnoea resulting from other diseases like left ventricular failure, COPD (Chronic Bronchitis, Emphysema), upper respiratory tract obstruction, bronchiectasis, cases of tuberculosis, interstitial lung disease/occupational lung disease, tropical pulmonary eosinophilia & allergic bronchopulmonary aspergillosis etc.

4.Patients having anaemia, pneumonia, tuberculosis, lung cancer, lung abscess and other such complicated conditions.

5.Patients having diabetes, hypertension, Chronic and Acute renal failure etc. conditions in which urination is markedly diminished or excessive were excluded.

6.HIV positive cases.

7.Pregnant/lactating mother.

8.Patients who need Salbutamol inhaler daily.

9.Patients having classical symptoms of Maha, Urdha, Chhinna and Kshudra Shwasa.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptomatic reliefTimepoint: 28days
Secondary Outcome Measures
NameTimeMethod
Symptomatic reliefTimepoint: 14days
© Copyright 2025. All Rights Reserved by MedPath